Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial

References

• Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, . Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005;366:2087–106.
   PubMed Web of Science ®Google Scholar
• Solin LJ, Harris EE, Orel SG, Glick J. Local-regional recurrence after breast conserving treatment or mastectomy. In: Harris JR, Lippman ME, Morrow M, Osborne CK, editors. Diseases of the breast. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004.
   Google Scholar
• Clemons M, Hamilton T, Goss P. Does treatment at the time of locoregional failure of breast cancer alter prognosis? Cancer Treat Rev 2001;27:83–97.
   PubMed Web of Science ®Google Scholar
• Gehl J, Skovsgaard T, Mir LM. Enhancement of cytotoxicity by electropermeabilization: An improved method for screening drugs. Anti-Cancer Drugs 1998;9:319–25.
   PubMed Web of Science ®Google Scholar
• Orlowski S, Belehradek Jr J, Paoletti C, Mir LM. Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 1988;37:4727–33.
   PubMed Web of Science ®Google Scholar
• Gothelf A, Mir LM, Gehl J. Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003;29:371–87.
   PubMed Web of Science ®Google Scholar
• Campana LG, Mocellin S, Basso M, Puccetti O, De Salvo GL, Chiarion-Sileni V, . Bleomycin-based electrochemotherapy: Clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol 2009;16:191–9.
   PubMed Web of Science ®Google Scholar
• Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, Snoj M, . Electrochemotherapy, an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. EJC Supplements 2006;4:3–13.
   Google Scholar
• Curatolo P, Quaglino P, Marenco F, Mancini M, Nardo T, Mortera C, . Electrochemotherapy in the treatment of kaposi sarcoma cutaneous lesions: A two-center prospective phase II trial. Ann Surg Oncol Epub 2011 Aug 6.
   Web of Science ®Google Scholar
• Matthiessen LW, Chalmers RL, Sainsbury DC, Veeramani S, Kessell G, Humphreys AC, . Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011; 50:621–9.
   PubMed Web of Science ®Google Scholar
• Whelan MC, Larkin JO, Collins CG, Cashman J, Breathnach O, Soden DM, . Effective treatment of an extensive recurrent breast cancer which was refractory to multimodal therapy by multiple applications of electrochemotherapy. EJC Supplements 2006;4:32–4.
   Google Scholar
• Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, . New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205–16.
   PubMed Web of Science ®Google Scholar
• Carr T, Moss T, Harris D. The DAS24: A short form of the Derriford Appearance Scale DAS59 to measure individual responses to living with problems of appearance. Br J Health Psychol 2005;10:285–98.
   PubMed Web of Science ®Google Scholar
• Mir LM, Gehl J, Sersa G, Collins CG, Garbay JR, Billard V, . Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrodes. EJC Supplements 2006;4:14–25.
   Web of Science ®Google Scholar
• Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1–10.
   PubMedGoogle Scholar
• Ohnuma T, Holland JF, Masuda H, Waligunda JA, Goldberg GA. Microbiological assay of bleomycin: Inactivation, tissue distribution, and clearance. Cancer 1974;33:1230–8.
   PubMed Web of Science ®Google Scholar
• Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, . Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008;98:388–98.
   PubMed Web of Science ®Google Scholar
• Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: Characterization and consequences for drug and gene delivery. Biochim Biophys Acta 2002;1569:51–8.
   PubMed Web of Science ®Google Scholar
• Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000;10:585–9.
   PubMed Web of Science ®Google Scholar
• Quaglino P, Mortera C, Osella-Abate S, Barberis M, Illengo M, Rissone M, . Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008;15:2215–22.
   PubMed Web of Science ®Google Scholar
• Domenge C, Orlowski S, Luboinski B, De BT, Schwaab G, Belehradek J, Jr., . Antitumor electrochemotherapy: New advances in the clinical protocol. Cancer 1996;77:956–63.
   PubMed Web of Science ®Google Scholar
• Mathes DD. Bleomycin and hyperoxia exposure in the operating room. Anesth Analg 1995;81:624–9.
   PubMed Web of Science ®Google Scholar
• Agerholm-Larsen B, Iversen HK, Ibsen P, Moller JM, Mahmood F, Jensen KS, . Preclinical validation of electrochemotherapy as an effective treatment for brain tumors. Cancer Res 2011;71:3753–62.
   PubMed Web of Science ®Google Scholar
• Edhemovic I, Gadzijev EM, Brecelj E, Miklavcic D, Kos B, Zupanic A, . Electrochemotherapy: A new technological approach in treatment of metastases in the liver. Technol Cancer Res Treat 2011;10:475–85.
   Google Scholar